A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activi...

por Espinoza, Manuel Antonio, Rojas, Rubén, Zaupa, Alessandro, Balmaceda, Carlos
Publicado 2021

Health and economic effects on patients with type 2 diabetes mellitus in the long run: predictions for the Chilean population

por Espinoza, Manuel Antonio, Abbott, Tomas, Passi, Alvaro, Balmaceda, Carlos
Publicado 2022

The socioeconomic distribution of life expectancy and healthy life expectancy in Chile

por Espinoza, Manuel Antonio, Severino, Rodrigo, Balmaceda, Carlos, Abbott, Tomas, Cabieses, Baltica
Publicado 2023

Economic evaluation of a multimorbidity patient centered care model implemented in the Chilean public health system

por Zamorano, Paula, Espinoza, Manuel Antonio, Varela, Teresita, Abbott, Tomas, Tellez, Alvaro, Armijo, Nicolás, Suarez, Francisco
Publicado 2023

Costs and consequences of chronic pain due to musculoskeletal disorders from a health system perspective in Chile

por Vargas, Constanza, Bilbeny, Norberto, Balmaceda, Carlos, Rodríguez, María Francisca, Zitko, Pedro, Rojas, Rubén, Eberhard, María Eliana, Ahumada, Marisol, Espinoza, Manuel Antonio
Publicado 2018